Abstract Body

Background: Understanding how to achieve efficient transduction of hematopoietic stem cells (HSCs), while preserving their self-renewing capacity, is key for applying lentivirus-based gene engineering methods in Phase I/II clinical trials. The sterile alpha motif (SAM) domain and HD domain-containing protein 1 (SAMHD1) was recently identified as a HIV-1 restriction factor in myeloid and resting CD4+ T cells that interferes with reverse transcription by decreasing the nucleotide pools. HIV-2 and SIV have evolved to counteract the effects of SAMHD1 by their accessory protein Vpx, which targets SAMHD1 for proteasomal degradation. We hypothesized that SAMHD1 also interferes with HIV-1-vector-based HSCs transduction. Methodology: We used Vpx-mediated degradation of SAMHD1, shRNA to SAMHD1, HIV-2- or SIV- based lentiviral vectors or provided an excess of deoxynucleoside triphosphates (dNTPs) or deoxynucleoside (dNs) to relieve a potential block of SAMHD1 in HSCs. In addition, Alu-PCR was used to identify and characterize the integrated provirus in HSCs and monocyte-derived macrophages (MDMs). Results: Our results show that SAMHD1 is highly expressed in HSCs cultured in a medium enriched with cytokines conventionally used for transduction of HSCs. In contrast, uncultured HSCs have poor SAMHD1 expression. Expression levels of SAMHD1 in cultured HSCs are comparable to those found in myeloid cells, including monocytes and MDMs. However, Vpx+ VLPs, dNs or shRNA for silencing SAMHD1 and HIV-2- or SIV-based lentiviral vectors do not relieve a potential block in reverse transcription in HSCs that would result in a higher transduction rate. Notably, while Vpx+ VLPs resulted in a vigorous decrease of SAMHD1 in HSCs, the remaining SAMHD1 level is still remarkably high. Last but not least, Vpx+ VLPs lead to a striking increase of dNTPs in MDMs but not HSCs. Conclusions: In summary, HSCs, unlike quiescent cells, express high levels of SAMHD1. However, the Vpx-mediated decrease of SAMHD1 levels was not associated with a higher lentiviral-based transduction rate. These data imply that other restriction factors might be operative in lentiviral transduction of HSCs.